[{"Assets_0_Q2_USD":4387100000.0,"CommonStockSharesOutstanding_0_Q2_shares":133318039.0,"EarningsPerShareBasic_1_Q2_USD":-0.16,"EarningsPerShareBasic_2_Q2_USD":-0.14,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"EarningsPerShareDiluted_2_Q2_USD":-0.14,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":176000000.0,"NetIncomeLoss_1_Q2_USD":-21900000.0,"NetIncomeLoss_2_Q2_USD":-18100000.0,"StockholdersEquity_0_Q2_USD":1005500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":132983262.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":129327188.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":132983262.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":129327188.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20171231","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180205"}]